Evaluation of the effect of Montelukast in allergic rhinitis, Evaluation of the effect of neotadine in the treatment of allergic rhinitis

Phase 2

Recruiting

• Conditions: allergic rhinitis.; Other allergic rhinitis; J30.89

• Registration Number: IRCT20211205053277N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Having moderate to severe allergic rhinitis
over 6 years of age
having informed consent

Exclusion Criteria

Asthma infection and adenoid hypertrophy
Patients with chronic diseases
Antihistamine use during the last 1 month
Systemic or topical corticosteroids
History of neotadine allergy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
asal symptom score. Timepoint: before treatment intervention and two months after treatment. Method of measurement: Nasal symptom scoring table.